Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient–Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study

INTRODUCTION: Luteinising hormone-releasing hormone agonist (LHRHa) injections are currently used in the treatment of advanced prostate cancer, but the frequency of injections may represent a burden to patients and healthcare services. The aim of this study was to collect real-world evidence about c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornford, Philip, Jefferson, Kieran, Cole, Owen, Gilbody, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359994/
https://www.ncbi.nlm.nih.gov/pubmed/32700031
http://dx.doi.org/10.1007/s40487-018-0087-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359994/
https://www.ncbi.nlm.nih.gov/pubmed/32700031
http://dx.doi.org/10.1007/s40487-018-0087-1

Ejemplares similares